PC cells can upregulate PSMA after acute AR blockade (99), while downregulation of PSMA is associated with tumor response to AR-directed treatment (100), and tumors can further upregulate PSMA at the time of AR-reactivation and treatment resistance (101). The gene discussed is FOLH1; the disease is neoplasm.